Event Partner Content Novel CNS Biomarkers Summit Europe Europe is rapidly becoming a hub for next-generation CNS biomarker innovation
Event Partner Content 4th Cell Therapy for Autoimmune Disease Summit Developers are racing to overcome challenges around safety, scalability, durability of response, and patient access
Event Partner Content 10th Complement-Based Drug Development Summit Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and autoimmune indications
Event Partner Content Better Antifibrotic Decisions Through Cross-Organ Insights The 10th Antifibrotic Drug Development Summit is the industry's only dedicated forum focused on cross-indication antifibrotic drug development
Event Partner Content 10th Dermatology Drug Development Summit The 10th Dermatology Drug Development Summit returns in 2026 as the leading premier forum dedicated to advancing the discovery, development, and commercialization of innovative therapies for inflam
Event Partner Content 2nd World-RNA Based Therapeutics & Vaccines Summit South Kor... Korea’s Forum to Advance mRNA, CircRNA & saRNA Medicines for Clinical & Commercial Readiness
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.